Search research articles
Contact Us
Filters
Showing results (31-40 of 60) with videos related to
Page
of 6
Sort By:
The New England Journal of Medicine
|
September 25, 2009
Anthracycline dose intensification in acute myeloid leukemia
Hugo F Fernandez, Zhuoxin Sun, Xiaopan Yao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 26, 2015
Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft-versus-host disease: phase I trial results
Joseph Pidala, Jongphil Kim, Brian C Betts, et al.
Haematologica
|
April 5, 2015
Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease
Joseph Pidala, Jongphil Kim, Melissa Alsina, et al.
Bone Marrow Transplantation
|
December 8, 2020
Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia
Richard T Maziarz, Mark Levis, Mrinal M Patnaik, et al.
American Journal of Hematology
|
June 16, 2018
Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experience
Chezi Ganzel, Zhuoxin Sun, Larry D Cripe, et al.
Cancer
|
May 15, 2023
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis
James M Foran, Zhuoxin Sun, Catherine Lai, et al.
Haematologica
|
June 13, 2012
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation
Joseph Pidala, Jongphil Kim, Heather Jim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 27, 2010
Severe hypoalbuminemia at day 90 predicts worse nonrelapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome
Mohamed A Kharfan-Dabaja, Julio C Chavez, Daohai Yu, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 9, 2017
TP53 and IDH2 Somatic Mutations Are Associated With Inferior Overall Survival After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome
Mohamed A Kharfan-Dabaja, Rami S Komrokji, Qing Zhang, et al.
Leukemia Research
|
November 4, 2022
Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling
Chezi Ganzel, Zhuoxin Sun, Timour Baslan, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 60) with videos related to
Sort By:
Page
of 6
The New England Journal of Medicine
|
September 25, 2009
Anthracycline dose intensification in acute myeloid leukemia
Hugo F Fernandez, Zhuoxin Sun, Xiaopan Yao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 26, 2015
Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft-versus-host disease: phase I trial results
Joseph Pidala, Jongphil Kim, Brian C Betts, et al.
Haematologica
|
April 5, 2015
Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease
Joseph Pidala, Jongphil Kim, Melissa Alsina, et al.
Bone Marrow Transplantation
|
December 8, 2020
Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia
Richard T Maziarz, Mark Levis, Mrinal M Patnaik, et al.
American Journal of Hematology
|
June 16, 2018
Very poor long-term survival in past and more recent studies for relapsed AML patients: The ECOG-ACRIN experience
Chezi Ganzel, Zhuoxin Sun, Larry D Cripe, et al.
Cancer
|
May 15, 2023
Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG-ACRIN analysis
James M Foran, Zhuoxin Sun, Catherine Lai, et al.
Haematologica
|
June 13, 2012
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation
Joseph Pidala, Jongphil Kim, Heather Jim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 27, 2010
Severe hypoalbuminemia at day 90 predicts worse nonrelapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome
Mohamed A Kharfan-Dabaja, Julio C Chavez, Daohai Yu, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 9, 2017
TP53 and IDH2 Somatic Mutations Are Associated With Inferior Overall Survival After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome
Mohamed A Kharfan-Dabaja, Rami S Komrokji, Qing Zhang, et al.
Leukemia Research
|
November 4, 2022
Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling
Chezi Ganzel, Zhuoxin Sun, Timour Baslan, et al.
Page
of 6